ABOUT
SIOPE BTG Annual Meeting & Educational Course 2026
An international scientific meeting bringing together leading experts in pediatric neuro-oncology to share research, clinical experience and collaboration.
About the Congress
The SIOPE Brain Tumour Group (BTG) Annual Meeting and the European Combined Neuro-Oncology Course 2026 will take place in Athens, Greece, from 15–19 September 2026.
This international scientific event brings together leading experts in pediatric neuro-oncology, including clinicians, researchers, and healthcare professionals dedicated to improving the diagnosis, treatment, and care of children and young people with brain tumours.
The event includes:
– Educational Course: 15–16 September 2026
– BTG Annual Scientific Meeting: 17–19 September 2026
Together, these events provide a unique opportunity for education, scientific exchange, and collaboration in the field of pediatric neuro-oncology
This international scientific event brings together leading experts in pediatric neuro-oncology, including clinicians, researchers, and healthcare professionals dedicated to improving the diagnosis, treatment, and care of children and young people with brain tumours.
The event includes:
– Educational Course: 15–16 September 2026
– BTG Annual Scientific Meeting: 17–19 September 2026
Together, these events provide a unique opportunity for education, scientific exchange, and collaboration in the field of pediatric neuro-oncology
About the SIOPE Brain Tumour Group
The SIOPE Brain Tumour Group (BTG) is a European multidisciplinary network of healthcare professionals and scientists involved in the research, treatment, and care of children, adolescents, and young adults with Central Nervous System (CNS) tumours.
The group includes specialists from multiple disciplines such as:
- Pediatric oncology
- Neurosurgery
- Radiation oncology
- Neuroradiology
- Neuropathology
- Translational and clinical research
The SIOPE BTG has successfully conducted pan-European clinical trials and continues to play a leading role in advancing knowledge and treatment in pediatric neuro-oncology.
